A centralized resource for genomic research in cancer
Official title: Director Genomics Shared Resource
Funded at Roswell Park Cancer Institute Corp · NIH-10977529 · Data updated 2026-11-12
This study is all about helping cancer researchers at Roswell Park use genetic information to create better, personalized treatments for patients like you, so you can get the most effective care based on your unique DNA.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $236,003 |
| NIH project number | 1R50CA283805-01A1 |
| Project ID | NIH-10977529 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include cancer patients who are seeking personalized treatment options based on genomic data.
✕Less likely to help
Patients with non-cancerous conditions or those not interested in genomic-based approaches may not benefit from this research.
What this research studies
This research focuses on providing support for genomic initiatives at the Roswell Park Comprehensive Cancer Center. It aims to enhance cancer research by offering expertise in assay design, sample preparation, and data analysis. Patients may benefit from personalized therapies developed through the analysis of their unique genetic makeup. The project facilitates collaboration among researchers to improve diagnostic applications and treatment strategies for cancer patients.
Why it matters
Potential benefit: If successful, this research could lead to more effective, personalized cancer treatments based on individual genetic profiles.
How similar studies have gone: Previous research has shown success in utilizing genomic data to develop personalized cancer therapies, indicating a promising approach.
Where this research is happening
-
Roswell Park Cancer Institute Corp
Buffalo, United States Active
Researchers
- Principal investigator: Singh, Prashant Kumar — Roswell Park Cancer Institute Corp
- Study coordinator: Singh, Prashant Kumar
Related research
Other NIH-funded projects on the same topics.
-
A network for sharing data and resources in immuno-oncology.
This study is all about bringing together experts to find better ways to treat cancer by understanding why some treatments don’t work and discovering new targets for the immune system, which could lead to more personalized and effective therapies for adults.
-
A network for sharing data and resources in immuno-oncology
This study is all about finding better ways to treat cancer using the body's immune system by working together with different experts to share information, which could lead to new treatments and help patients like you have more effective options.
-
Targeting retrotransposons to help kids with hard-to-treat cancers like neuroblastoma
Aims to repurpose safe antiviral drugs to block retrotransposons in children with relapsed or refractory neuroblastoma to improve outcomes.
-
MedSupport: Helping families overcome barriers to kids' chemotherapy medicines
This program offers extra support to parents of children with acute lymphoblastic leukemia to help them give home chemotherapy medicines more reliably.
-
Innate immune cells and female lung cancer risk
A study exploring how certain immune cells in the lungs may contribute to lung cancer in young women who don’t smoke.
-
Effect of ONP filler materials on how fast nicotine is delivered
This grant tests how different filler materials in oral nicotine pouches affect how quickly nicotine is released and absorbed in the mouth.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.